cobas® Influenza A/B and RSV Assay

We put a lab in a tube...

The cobas® Influenza A/B and RSV nucleic acid test for use on the cobas® Liat® System is an automated multiplex real-time RT-PCR assay for the rapid in vitro qualitative detection and discrimination of Influenza A virus and Influenza B virus and respiratory syncytial virus RNA in nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection in conjunction with clinical and epidemiological risk factors.

Features and Benefits

  • Small: The compact cobas® Liat® benchtop analyzer is smaller than a shoebox and conveniently designed for space-challenged testing locations
  • Simple: The cobas Liat® System is fully-automated with touchscreen guided operation, requiring minimal training and hands-on time. Add nothing more than a patient sample.
  • Swift: Sample to results in 20 minutes or less. Single assay runs allow time-sensitive testing and reporting.
  • Secure: Sealed-tube design eliminates operator contact with reagents or other chemicals. Closed system with multiple controls reduce the potential for human error.

Intended Use

The cobas® Influenza A/B and RSV Nucleic acid test for use on the cobas® Liat® System is an automated multiplex real-time RT-PCR assay for the rapid in vitro qualitative detection and discrimination of Influenza A virus, Influenza B virus and respiratory syncytial virus (RSV) RNA in nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection in conjunction with clinical and epidemiological risk factors.  The test is intended for use as an aid in the differential diagnosis of Influenza A, Influenza B, and RSV in humans and is not intended to detect Influenza C.

The cobas® Liat® System is not commercially available in all markets.